Pharmaron: Announcement on changes in shareholdings of shareholders holding more than 5% of shares touching an integral multiple of 1%
Securities code: 300759 Securities abbreviation: Pharmaron Announcement number: 2026-049
Pharmaron Chemical (Beijing) New Drug Technology Co., Ltd.
Announcement on changes in shareholdings of shareholders holding more than 5% of the shares touching an integral multiple of 1%
Shenzhen Xinzhong Kangcheng Investment Partnership (Limited Partnership), a shareholder holding more than 5% of the company's shares, and Shenzhen Xinzhong Longcheng Investment Partnership (Limited Partnership), a person acting in concert, guarantee that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Pharmaron Chemicals (Beijing) New Drug Technology Co., Ltd. (hereinafter referred to as the "Company") recently received a letter from Shenzhen Xinzhong Kangcheng Investment Partnership (Limited Partnership) (hereinafter referred to as "Xinzhong Kangcheng"), a shareholder holding more than 5% of the company's shares, and its agreement The action person, Shenzhen Xinzhong Longcheng Investment Partnership (Limited Partnership) (hereinafter referred to as "Xinzhong Longcheng"), issued the "Notice of Progress of Shareholding Reduction" and learned that the shareholding changes of Xinzhong Kangcheng and Xinzhong Longcheng reached an integral multiple of 1% due to the reduction of their shareholdings. The relevant situation is now announced as follows:
1. Specific circumstances when the shareholding ratio reaches an integral multiple of 1%
1.Basic situation
Information disclosure obligor
Shenzhen Xinzhong Kangcheng Investment Partnership (Limited Partnership)
(1)
Xiangjiang Financial Residence, No. 3046, Xinghai Avenue, Nanshan Street, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen
Building 1314-B8
Information disclosure obligor
Shenzhen Xinzhong Longcheng Investment Partnership (Limited Partnership)
(2)
Xiangjiang Financial Residence, No. 3046, Xinghai Avenue, Nanshan Street, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen
Building 1314-B9
Equity change time July 1, 2026
Due to their own capital needs, Xinzhong Kangcheng and Xinzhong Longcheng reduced their holdings in the company by a total of 17,800,000 from June 16, 2026 to July 1, 2026. Equity changes
shares. Among them, Xinzhong Kangcheng reduced its holdings of 7,600,000 shares of the company through centralized bidding transactions and 5,000,000 shares of the company through block transactions; Xinzhong Longcheng reduced its holdings of 5,200,000 shares of the company through centralized bidding transactions and 0 shares of the company through block transactions. This shareholding reduction is carried out in accordance with the disclosed plan. The implementation of the shareholding reduction plan will not have a significant impact on the company's governance structure and sustainable operations, and will not lead to changes in the company's control.
Stock abbreviation Pharmaron Stock Code 300759
Direction of change Up □ Down √ Persons acting in concert Yes √ No □
Is it the largest shareholder or actual controller? Yes□ No√
- Changes in equity this time
Type of shares Number of shares reduced (shares) Change ratio (%) A shares (Xinzhong Kangcheng) 12,600,000 0.69
A shares (Xinzhong Longcheng) 5,200,000 0.28
Total 17,800,000 0.97
Centralized trading through stock exchanges √
The method of this equity change
Block trades through stock exchanges √
(multiple choices available)
Others □
- Before and after this change, investors and their persons acting in concert have shares in listed companies.
Shares held before this change Nature of shares held after this change
Ratio to total equity Number of shares to total equity (shares) Number of shares (shares)
Example Note 1 (%) Ratio Note 1 (%) Shares held by Xinzhong Kangcheng 214,597,333 11.68 201,997,333 10.99 Including: No selling conditions
214,597,333 11.68 201,997,333 10.99 shares
Limited sales conditions
0 0.00 0 0.00 shares
Shares held by Xinzhong Longcheng 5,200,000 0.28 0 0.00 Including: No selling conditions
5,200,000 0.28 0 0.00 shares
Limited sales conditions
0 0.00 0 0.00 shares
Total 219,797,333 11.96 201,997,333 10.99
- Implementation of commitments, plans, etc.
Yes √ No □
Is this change a fulfillment of obligations? On April 30, 2026, the company disclosed the "Commitments Made by Shareholders Holding More than 5% of the Shares and Pre-Disclosure Announcement of Shareholdings" (Announcement No.: 2026-033). Under the intention and plan to reduce holdings, from May 27, 2026 to June 15, 2026, Xinzhong Longcheng reduced its holdings by a total of 5,516,600 shares. In 2026 June 16, 2026 to July 2026
On March 1, Xinzhong Kangcheng and Xinzhong Longcheng reduced their holdings by a total of 17,800,000 shares. This reduction plan has not yet been completed.
This equity change is consistent with the previously disclosed shareholding reduction plan. The reduction amount is within the scope of the disclosed shareholding reduction plan. There is no violation of the disclosed shareholding reduction plan and
relevant commitments.
Does this change exist?
Violation of the Securities Law
Municipal Company Acquisition Management Office
Law and other laws and administrative Yes □ No √ regulations, departmental rules,
Normative documents and deep exchanges
Business rules and other regulations
situation
- Shares with restricted voting rights
According to Section 1 of the Securities Law
The provisions of Article 63, yes □ no √ whether they exist or not, shall not be exercised
voting shares
- Further explanation of the increase in shareholding by shareholders above 30% (if applicable)
Not applicable
Documents available for inspection
"Letter of Notification of Shareholding Reduction Progress" issued by Xinzhong Kangcheng and Xinzhong Longcheng;
Other documents required by Shenzhen Stock Exchange.
Note 1: The company’s total share capital is 1,837,283,628 shares.
Announcement is hereby made.
Board of Directors of Pharmaron Chemical (Beijing) New Drug Technology Co., Ltd.
July 2, 2026